Abstract
Purpose
The aim of this study was to compare the outcomes of surgery and stereotactic body radiotherapy (SBRT) for elderly clinical stage I non-small cell lung cancer (NSCLC) patients.
Methods
Patients ≥80 years of age with clinical stage I NSCLC between August 2008 and December 2014 were treated either surgery or SBRT. Propensity score matching was performed to reduce bias in various clinicopathological factors.
Results
Surgery was performed in 57 cases and SBRT in 41 cases. In the surgery group, the operations included 34 lobectomies and 23 sublobar resections. In the SBRT group, 27 cases were given 48 Gy in 4 fractions, and 14 were given 60 Gy in 10 fractions. Similar characteristics were identified in age (82 years), gender (male:female ratio 2:1), tumor size (2.2 cm), carcinoembryonic antigen (3.6 ng/ml), Charlson comorbidity index (1), Glasgow prognostic scale (0), and forced expiratory volume in 1 s (1.7 L) after matching. Before matching, the 5-year overall survival (OS) in surgery (68.3%) was significantly better than that in SBRT (47.4%, p = 0.02), and the 5-year disease-specific survival (DSS) (94.1%, 78.2%, p = 0.17) was not significantly different between the groups. The difference in the 5-year OS became non-significant between the matched pairs (57.0%, 49.1%, p = 0.56).
Conclusions
The outcomes of surgery and SBRT for elderly patients with the early stage NSCLC were roughly the same.
Similar content being viewed by others
References
Ministry of Health, Labour and Welfare of Japan. Abridged life tables for Japan 2013. Tokyo: Government of Japan; 2013. http://www.mhlw.go.jp/toukei/saikin/hw/life/life13/. Accessed 1 Oct 2016.
Guerra M, Neves P, Miranda J. Surgical treatment of non-small-cell lung cancer in octogenarians. Interact Cardiovasc Thorac Surg. 2013;16:673–80.
Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small-cell lung cancer. Prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53.
Umezu H, Miyoshi S, Araki O, Karube Y, Tamura M, Kobayashi S, et al. Efficacy of functional operability algorithm for octogenarians with primary lung cancer. Gen Thorac Cardiovasc Surg. 2012;60:36–42.
Endo H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43:514–20.
Okada A, Hirono T, Watanabe T. Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer. Gen Thorac Cardiovasc Surg. 2012;60:97–103.
Eba J, Nakamura K, Mizusawa J, Suzuki K, Nagata Y, Koike T, et al. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). Jpn J Clin Oncol. 2016;46:748–53.
Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorac Surg. 2008;85:406–11.
Saji H, Ueno T, Nakamura H. Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303). Gen Thorac Cardiovasc Surg. 2016;64:634–5.
Mokhles S, Verstegen N, Maat A, Birim Ö, Bogers A, Mohkles MM, et al. Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. Lung Cancer. 2015;87:283–9.
Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholzz TA, et al. Lobectomy, sublobar resection, and stereotactic radiation for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014;149:1244–53.
Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer. 2014;50:2932–8.
Paul S, Lee PC, Mao J, Isaacs AJ, Sedrakyn A. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis. BMJ. 2016;354:i3570.
Chang JY, Senan S, Paul MA, Mehran RJ, Luie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trial. Lancet Oncol. 2015;16:630–7.
Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N, et al. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015;99:1122–9.
Rosen JE, Salazar MC, Wang A, Yu JB, Decker RH, Kin AW, et al. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016;152:44–54.
Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, et al. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thorac Surg. 2009;8:89–92.
Katayama H, Kurokawa Y, Nakamura K, Itoh H, Kanemitsu Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.
Kanzaki R, Inoue M, Minami M, Shintani Y, Funaki S, Kawamura T, et al. Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution. Surg Today. 2017;47:27–34.
Shiga, M, Maeda, H, Oba, K, Okamoto K, Namikawa T, Fujisawa K, et al. Safety of laparoscopic surgery for colorectal cancer in patients over 80 years old: a propensity score matching study. Surg Today. 2017. (epub ahead of print).
Miyazaki T, Sakai T, Tsuchiya T, Yamasaki N, Tagawa T, Mine M, et al. Assessment and follow-up of intercostal nerve damage after video-assisted thoracic surgery. Eur J Cardiothorac Surg. 2011;39:1033–9.
Muraoka M, Oka T, Akamine S, Tagawa T, Sasaki N, Ikuta Y, et al. Surgical treatment for lung cancer in octogenarians. Surg Today. 2005;35:725–31.
Solda F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol. 2013;109:1–7.
Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, et al. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;86:257–63.
Nakagawa T, Negoro Y, Matsuoka T, Okumura N, Dodo Y. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M non-small cell lung cancer. Respir Investig. 2014;52:221–6.
Nanda RH, Liu Y, Gillespie TW, Mikell JL, Ramalimgam SS, Fernandez FG, et al. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: a national cancer data base analysis. Cancer. 2015;23:4222–30.
Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol. 2013;52:1552–8.
Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93:989–96.
Takahashi N, Sawabata N, Kawamura M, Ohtsuka T, Horio H, Sakaguchi H, et al. Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication. Gen Thorac Cardiovasc Surg. 2016;64(8):470–5.
Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 2015;121:2341–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
None.
Conflict of interest
The authors declare no competing financial conflicts of interest.
Rights and permissions
About this article
Cite this article
Miyazaki, T., Yamazaki, T., Nakamura, D. et al. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis. Surg Today 47, 1476–1483 (2017). https://doi.org/10.1007/s00595-017-1536-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-017-1536-4